Concepedia

Vanessa S. Marsden

VS

Statistics

Publications

8

Citations

1.3K

H-Index

8

Active since

2002

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

Murdoch Children's Research Institute

Vertex Pharmaceuticals (United States)

University of Rome Tor Vergata

Hanson Institute

Vanessa S. Marsden is an author at Walter and Eliza Hall Institute of Medical Research specializing in apoptotic signaling, apoptosis, and apoptosis regulation.

Publications per year

2002–2005

8

Publications

8

Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome

Vanessa S. Marsden, Liam O’Connor, Lorraine A. O’Reilly et al. · Nature · 2002 · 568 citations

, , +14

Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9

Lorraine A. O’Reilly, Paul G. Ekert, Natasha L. Harvey et al. · Cell Death and Differentiation · 2002 · 191 citations

, , +12

Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die

Paul G. Ekert, Stuart H. Read, John Silke et al. · The Journal of Cell Biology · 2004 · 181 citations · Full text

, , +17

Bcl-2–regulated apoptosis and cytochrome <i>c</i> release can occur independently of both caspase-2 and caspase-9

Vanessa S. Marsden, Paul G. Ekert, Mark F. van Delft et al. · The Journal of Cell Biology · 2004 · 99 citations · Full text

, , +16

Negative selection of semimature CD4 <sup>+</sup> 8 <sup>-</sup> HSA <sup>+</sup> thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling

Andreas Villunger, Vanessa S. Marsden, Yifan Zhan et al. · Proceedings of the National Academy of Sciences · 2004 · 70 citations · Full text

, , +17

1–5 of 8